163 related articles for article (PubMed ID: 37531469)
1. Slow Dissociation from the PARP1-HPF1 Complex Drives Inhibitor Potency.
Stojanovic P; Luger K; Rudolph J
Biochemistry; 2023 Aug; 62(16):2382-2390. PubMed ID: 37531469
[TBL] [Abstract][Full Text] [Related]
2. [Poly(ADP-Ribose) Polymerases 1 and 2: Classical Functions and Interaction with New Histone Poly(ADP-Ribosyl)ation Factor HPF1].
Kurgina TA; Lavrik OI
Mol Biol (Mosk); 2023; 57(2):254-268. PubMed ID: 37000654
[TBL] [Abstract][Full Text] [Related]
3. High-throughput screening assay for PARP-HPF1 interaction inhibitors to affect DNA damage repair.
Dhakar SS; Galera-Prat A; Lehtiö L
Sci Rep; 2024 Feb; 14(1):3875. PubMed ID: 38365924
[TBL] [Abstract][Full Text] [Related]
4. HPF1-dependent histone ADP-ribosylation triggers chromatin relaxation to promote the recruitment of repair factors at sites of DNA damage.
Smith R; Zentout S; Rother M; Bigot N; Chapuis C; Mihuț A; Zobel FF; Ahel I; van Attikum H; Timinszky G; Huet S
Nat Struct Mol Biol; 2023 May; 30(5):678-691. PubMed ID: 37106138
[TBL] [Abstract][Full Text] [Related]
5. HTS discovery of PARP1-HPF1 complex inhibitors in cancer.
Kellett T; Noor R; Zhou Q; Esquer H; Sala R; Stojanovic P; Rudolph J; Luger K; LaBarbera DV
SLAS Discov; 2023 Dec; 28(8):394-401. PubMed ID: 37844763
[TBL] [Abstract][Full Text] [Related]
6. Dual function of HPF1 in the modulation of PARP1 and PARP2 activities.
Kurgina TA; Moor NA; Kutuzov MM; Naumenko KN; Ukraintsev AA; Lavrik OI
Commun Biol; 2021 Nov; 4(1):1259. PubMed ID: 34732825
[TBL] [Abstract][Full Text] [Related]
7. Histone Parylation factor 1 contributes to the inhibition of PARP1 by cancer drugs.
Rudolph J; Roberts G; Luger K
Nat Commun; 2021 Feb; 12(1):736. PubMed ID: 33531508
[TBL] [Abstract][Full Text] [Related]
8. HPF1 and nucleosomes mediate a dramatic switch in activity of PARP1 from polymerase to hydrolase.
Rudolph J; Roberts G; Muthurajan UM; Luger K
Elife; 2021 Mar; 10():. PubMed ID: 33683197
[TBL] [Abstract][Full Text] [Related]
9. HPF1 remodels the active site of PARP1 to enable the serine ADP-ribosylation of histones.
Sun FH; Zhao P; Zhang N; Kong LL; Wong CCL; Yun CH
Nat Commun; 2021 Feb; 12(1):1028. PubMed ID: 33589610
[TBL] [Abstract][Full Text] [Related]
10. The HPF1-dependent histone PARylation catalyzed by PARP2 is specifically stimulated by an incised AP site-containing BER DNA intermediate.
Kurgina TA; Moor NA; Kutuzov MM; Lavrik OI
DNA Repair (Amst); 2022 Dec; 120():103423. PubMed ID: 36356486
[TBL] [Abstract][Full Text] [Related]
11. HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation.
Suskiewicz MJ; Zobel F; Ogden TEH; Fontana P; Ariza A; Yang JC; Zhu K; Bracken L; Hawthorne WJ; Ahel D; Neuhaus D; Ahel I
Nature; 2020 Mar; 579(7800):598-602. PubMed ID: 32028527
[TBL] [Abstract][Full Text] [Related]
12. Interactions of PARP1 Inhibitors with PARP1-Nucleosome Complexes.
Maluchenko N; Koshkina D; Korovina A; Studitsky V; Feofanov A
Cells; 2022 Oct; 11(21):. PubMed ID: 36359739
[TBL] [Abstract][Full Text] [Related]
13. HPF1 dynamically controls the PARP1/2 balance between initiating and elongating ADP-ribose modifications.
Langelier MF; Billur R; Sverzhinsky A; Black BE; Pascal JM
Nat Commun; 2021 Nov; 12(1):6675. PubMed ID: 34795260
[TBL] [Abstract][Full Text] [Related]
14. HPF1/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation Activity.
Gibbs-Seymour I; Fontana P; Rack JGM; Ahel I
Mol Cell; 2016 May; 62(3):432-442. PubMed ID: 27067600
[TBL] [Abstract][Full Text] [Related]
15. HPF1 regulates tendon stem/progenitor cell senescence and tendon repair via PARP1-mediated poly-ADP ribosylation of HuR.
Han W; Gu D; Chen H; Tao X; Chen L
Genes Genomics; 2024 Jan; 46(1):27-36. PubMed ID: 37713069
[TBL] [Abstract][Full Text] [Related]
16. Asymmetric nucleosome PARylation at DNA breaks mediates directional nucleosome sliding by ALC1.
Bacic L; Gaullier G; Mohapatra J; Mao G; Brackmann K; Panfilov M; Liszczak G; Sabantsev A; Deindl S
Nat Commun; 2024 Feb; 15(1):1000. PubMed ID: 38307862
[TBL] [Abstract][Full Text] [Related]
17. Modular antibodies reveal DNA damage-induced mono-ADP-ribosylation as a second wave of PARP1 signaling.
Longarini EJ; Dauben H; Locatelli C; Wondisford AR; Smith R; Muench C; Kolvenbach A; Lynskey ML; Pope A; Bonfiglio JJ; Jurado EP; Fajka-Boja R; Colby T; Schuller M; Ahel I; Timinszky G; O'Sullivan RJ; Huet S; Matic I
Mol Cell; 2023 May; 83(10):1743-1760.e11. PubMed ID: 37116497
[TBL] [Abstract][Full Text] [Related]
18. Studying PAR-Dependent Chromatin Remodeling to Tackle PARPi Resistance.
Andronikou C; Rottenberg S
Trends Mol Med; 2021 Jul; 27(7):630-642. PubMed ID: 34030964
[TBL] [Abstract][Full Text] [Related]
19. The Ubiquitin Ligase TRIP12 Limits PARP1 Trapping and Constrains PARP Inhibitor Efficiency.
Gatti M; Imhof R; Huang Q; Baudis M; Altmeyer M
Cell Rep; 2020 Aug; 32(5):107985. PubMed ID: 32755579
[TBL] [Abstract][Full Text] [Related]
20. PARP1 changes from three-dimensional DNA damage searching to one-dimensional diffusion after auto-PARylation or in the presence of APE1.
Liu L; Kong M; Gassman NR; Freudenthal BD; Prasad R; Zhen S; Watkins SC; Wilson SH; Van Houten B
Nucleic Acids Res; 2017 Dec; 45(22):12834-12847. PubMed ID: 29121337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
